Dogecoin Cash, Inc. (CBDS)
- Previous Close
0.0270 - Open
0.0290 - Bid 0.0270 x 30449500
- Ask 0.0289 x 10579900
- Day's Range
0.0264 - 0.0290 - 52 Week Range
0.0028 - 0.1662 - Volume
361,183 - Avg. Volume
629,457 - Market Cap (intraday)
3.799M - Beta (5Y Monthly) 2.86
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Dogecoin Cash, Inc., through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. It also develops Lozenges for relief; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC, as well as intends to offer hi branded men's and women's fashion from suppliers through its www.cbds.com website. In addition, the company holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and cannabis industries. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.
www.cbds.com4
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CBDS
View MorePerformance Overview: CBDS
Trailing total returns as of 6/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CBDS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CBDS
View MoreValuation Measures
Market Cap
3.83M
Enterprise Value
4.03M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.12
Price/Book (mrq)
--
Enterprise Value/Revenue
5.28
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-214.45%
Return on Assets (ttm)
-21.20%
Return on Equity (ttm)
-1,115.28%
Revenue (ttm)
762.05k
Net Income Avi to Common (ttm)
-1.63M
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
360.51k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-106.08k